Form 8-K - Current report:
SEC Accession No. 0001593034-22-000034
Filing Date
2022-04-29
Accepted
2022-04-29 07:02:41
Documents
13
Period of Report
2022-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K endp-20220429.htm   iXBRL 8-K 58313
  Complete submission text file 0001593034-22-000034.txt   213306

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT endp-20220429.xsd EX-101.SCH 2216
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT endp-20220429_def.xml EX-101.DEF 4292
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT endp-20220429_lab.xml EX-101.LAB 27755
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT endp-20220429_pre.xml EX-101.PRE 15132
7 EXTRACTED XBRL INSTANCE DOCUMENT endp-20220429_htm.xml XML 10753
Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filer) CIK: 0001593034 (see all company filings)

EIN.: 680683755 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36326 | Film No.: 22870067
SIC: 2834 Pharmaceutical Preparations